Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma

In this study, we analyzed the long-term outcome of a risk-adapted transplantation strategy for mantle cell lymphoma in 121 patients enrolled in sequential transplantation protocols. Notable developments over the 17-year study period were the addition of rituximab to chemotherapy and preparative reg...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood Jg. 113; H. 18; S. 4144
Hauptverfasser:	Tam, Constantine S, Bassett, Roland, Ledesma, Celina, Korbling, Martin, Alousi, Amin, Hosing, Chitra, Kebraei, Partow, Harrell, Robyn, Rondon, Gabriela, Giralt, Sergio A, Anderlini, Paolo, Popat, Uday, Pro, Barbara, Samuels, Barry, Hagemeister, Frederick, Medeiros, L Jeffrey, Champlin, Richard E, Khouri, Issa F
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 30.04.2009
Schlagworte:	Adult Aged Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Combined Modality Therapy Feasibility Studies Female Graft vs Host Disease - therapy Hematopoietic Stem Cell Transplantation Humans Lymphoma, Mantle-Cell - mortality Lymphoma, Mantle-Cell - therapy Male Middle Aged Prognosis Radiotherapy Dosage Retrospective Studies Risk Factors Rituximab Survival Rate Transplantation Conditioning Transplantation, Autologous Treatment Outcome
ISSN:	1528-0020, 1528-0020
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!